🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral vs injectable GLP-1: bioavailability and efficacy comparison — what worked for you? Page 3

Oral vs injectable GLP-1: bioavailability and efficacy comparison — what worked for you?

TinaHashiRN Thu, May 2, 2024 at 8:46 PM 17 replies 2,275 viewsPage 3 of 4
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
May 4, 2024 at 10:46 PM#11
PeptideChemSF said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

30 5BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 27 others
Reply Quote Save Share Report
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
May 6, 2024 at 5:26 AM#12
kate.chem said:
The pharmacokinetics explain nearly every practical question asked here.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

29 4rachel_ABQ, traveltech_sara, AttorneyGrant and 26 others
Reply Quote Save Share Report
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
May 7, 2024 at 12:06 PM#13
PeptideChemSF said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

Pushing back on PeptideChemSF here. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

28 3GraceAZ_72, carl_compliance, DanielChem_CHI and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
May 8, 2024 at 6:47 PM#14

The figures, for anyone assembling their own picture. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: May 8, 2024 at 8:47 PM
27 2Dr.PeteFamMed, claudia_zurich, nancy_portland and 24 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 10, 2024 at 1:29 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

26 1PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 23 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register